Regulatory Changes Unpacked:
Expert Insights into the FDA's Oversight of LDTs in Digital Pathology
Thursday, May 23
3 - 4 PM ET
Member Rate: Complimentary!
Non-Member Rate: $100 (Individual membership is $100 & FREE for trainees!)
The Digital Pathology Association is hosting an informative webinar focused on the changes to the FDA's oversight of Lab Developed Tests (LDTs) and their implications for digital pathology. This session will feature a panel of distinguished experts from the fields of pathology, industry, regulatory affairs, and healthcare law. They will provide valuable insights and discuss the potential impacts of these regulatory changes on the practice and advancement of digital pathology. Participants will have the opportunity to engage directly with the panelists during a Q&A session, making this a must-attend event for professionals seeking to understand how these new regulations will shape the future of pathology labs and diagnostic practices. The webinar aims to equip attendees with the knowledge and strategies needed to navigate this evolving regulatory landscape.
Additional References:
Mike Quick, CT (ASCP)
President, Digital Pathology Association
VP, R&D, Cytology & Oncology, Hologic
John Groth, MD
Pathologist
Endeavor Health
Jeff Gibbs
Director
Hyman, Phelps & McNamara, P.C.
Staci Kearney, PhD, RAC
Founder and Chief Executive Officer
Elevation Strategic Development
NOT A DPA MEMBER? JOIN TODAY!
Individual membership is just $100 - and FREE for trainees!
Connect with 4,000+ digital pathology professionals from all around the world! The DPA fosters an exchange of ideas that helps our members understand, navigate, and influence the future of pathology. In addition to complimentary webinars, members receive access to:
For more information on the benefits and privileges of membership, please click here.